Mohamed A Elkablawy
Overview
Explore the profile of Mohamed A Elkablawy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aljuhani N, Elkablawy M, Elbadawy H, Alahmadi A, Aloufi A, Farsi S, et al.
J Taibah Univ Med Sci
. 2020 Jan;
14(6):553-559.
PMID: 31908644
Objectives: To investigate the tissue-protective effects of Ajwa date fruits (a Prophetic medicinal remedy) against acute diclofenac toxicity. Methods: Albino Sprague-Dawley rats were allocated to four experimental groups: a negative...
2.
El-Agamy D, Mohamed G, Ahmed N, Elkablawy M, Elfaky M, Elsaed W, et al.
Inflammopharmacology
. 2019 Jun;
28(1):153-163.
PMID: 31218570
Tovophyllin A (TA) is a xanthone isolated from Garcinia mangostana L. (GM, Guttiferae) pericarps that possesses various beneficial bioactivities. However, its protective effects on acute lung injury (ALI) and lung...
3.
El-Agamy D, Ibrahim S, Ahmed N, Khoshhal S, Abo-Haded H, Elkablawy M, et al.
Int Immunopharmacol
. 2019 Apr;
72:429-436.
PMID: 31030099
Endophytic fungi have known as a promising source of secondary metabolites. γ-Butyrolactones are a class of metabolites reported from Aspergillus genus, which attracted much attention for their bioactivities. This study...
4.
El-Agamy D, El-Harbi K, Khoshhal S, Ahmed N, Elkablawy M, Shaaban A, et al.
Cancer Manag Res
. 2018 Dec;
11:47-61.
PMID: 30588110
Background/purpose: Pristimerin (Pris) is triterpenoid compound with many biological effects. Until now, nothing is known about its effect on doxorubicin (DOX)-induced cardiotoxicity. Hence, this study investigated the impact of Pris...
5.
Ahmed N, Aljuhani N, Al-Hujaili H, Al-Hujaili M, Elkablawy M, Noah M, et al.
J Biochem Mol Toxicol
. 2018 Oct;
32(12):e22227.
PMID: 30273971
Valproate is a widely used drug against epilepsy and several other neurological disorders although it has deleterious hepatotoxic side effects. The current study was designed to test if agmatine as...
6.
El-Agamy D, Almaramhy H, Ahmed N, Bojan B, Alrohily W, Elkablawy M
Cell Physiol Biochem
. 2018 May;
47(2):523-534.
PMID: 29794447
Background/aims: Phosphodiesterase-5 inhibitors have beneficial effects in multiple liver diseases possibly through the reduction of oxidative stress and inflammatory response. However, these effects have not yet been examined in cholestatic...
7.
Ibrahim S, El-Agamy D, Abdallah H, Ahmed N, Elkablawy M, Mohamed G
Food Funct
. 2018 May;
9(6):3291-3300.
PMID: 29790527
Garcinia mangostana L. (GM, family Guttiferae) is one of the most widely recognized tropical fruits. GM is a wealthy pool of xanthones that exhibit a wide range of bioactivities. Tovophyllin...
8.
El-Agamy D, Shaaban A, Almaramhy H, Elkablawy S, Elkablawy M
Front Pharmacol
. 2018 Apr;
9:292.
PMID: 29643811
Pristimerin (Pris) is bioactive natural quinonoid triterpene that has anti-inflammatory and anti-cancer activities. Meanwhile, its effect against hepatitis needs to be elucidated. This investigation aimed to evaluate the ability of...
9.
El-Kholy A, Elkablawy M, El-Agamy D
Biomed Pharmacother
. 2017 Jun;
92:519-527.
PMID: 28575809
This study targeted to test the potential protective role of lutein against lung and liver damage associated with cyclophosphamide (CP) administration. Lutein was given orally for 5days at two different...
10.
Abo-Haded H, Elkablawy M, Al-Johani Z, Al-Ahmadi O, El-Agamy D
PLoS One
. 2017 Mar;
12(3):e0174295.
PMID: 28334048
Sitagliptin is selective dipeptidyl peptidase-4 inhibitor (DPP4-I), used clinically as a new oral anti-diabetic agent. This study explored the underlying mechanisms of the hepatoprotective role of sitagliptin pretreatment against methotrexate...